SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10963636
Source:
http://linkedlifedata.com/resource/pubmed/id/10963636
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0079083
,
umls-concept:C0144576
,
umls-concept:C0205179
,
umls-concept:C0282461
,
umls-concept:C1140680
pubmed:issue
17
pubmed:dateCreated
2000-9-19
pubmed:abstractText
To determine the side effects and feasibility of cisplatin and carboplatin each in combination with paclitaxel as front-line therapy in advanced epithelial ovarian cancer.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0732-183X
pubmed:author
pubmed-author:EngelholmS ASA
,
pubmed-author:HansenMM
,
pubmed-author:HirschF RFR
,
pubmed-author:LundBB
,
pubmed-author:NeijtJ PJP
,
pubmed-author:SessaCC
,
pubmed-author:SorensenP GPG
,
pubmed-author:TuxenM KMK
,
pubmed-author:de SwartC ACA
,
pubmed-author:van HouwelingenH CHC
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3084-92
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10963636-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:10963636-Carboplatin
,
pubmed-meshheading:10963636-Carcinoma
,
pubmed-meshheading:10963636-Cisplatin
,
pubmed-meshheading:10963636-Drug Administration Schedule
,
pubmed-meshheading:10963636-Epithelium
,
pubmed-meshheading:10963636-Feasibility Studies
,
pubmed-meshheading:10963636-Female
,
pubmed-meshheading:10963636-Humans
,
pubmed-meshheading:10963636-Infusions, Intravenous
,
pubmed-meshheading:10963636-Middle Aged
,
pubmed-meshheading:10963636-Ovarian Neoplasms
,
pubmed-meshheading:10963636-Paclitaxel
,
pubmed-meshheading:10963636-Survival Analysis
,
pubmed-meshheading:10963636-Taxoids
pubmed:year
2000
pubmed:articleTitle
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.
pubmed:affiliation
University Medical Center Utrecht, The Netherlands. j.p.neijt@digd.azu.nl
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase III